Virpax plans three trials based on platform drug delivery systems in 2024
Pharmaceutical Technology
JULY 11, 2023
Preclinical work is currently underway for all three candidates, with the first two trials set to start by mid-2024.
Pharmaceutical Technology
JULY 11, 2023
Preclinical work is currently underway for all three candidates, with the first two trials set to start by mid-2024.
XTalks
OCTOBER 27, 2021
Genentech’s ocular implant drug delivery system for treatment of macular degeneration has received approval from the US Food and Drug Administration (FDA). Susvimo delivers ranibizumab via a port delivery system into a surgically placed implant in the eye, allowing for continuous delivery of the drug.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
XTalks
AUGUST 14, 2024
The US Food and Drug Administration (FDA) has approved Galderma’s monoclonal antibody Nemluvio (nemolizumab) for the treatment of adult patients with the chronic skin condition prurigo nodularis. A significant percentage of patients also reported reduced sleep disturbances by Week 16 in both clinical trials.
Cloudbyz
MAY 15, 2023
Clinical trials are the backbone of medical research, paving the way for new treatments, drugs, and therapeutic procedures that can potentially revolutionize healthcare. While the focus is often on the promising outcomes these trials may yield, it’s crucial not to overlook the importance of participant safety during the process.
Pharmaceutical Technology
AUGUST 12, 2022
In August 2019, the parties entered a partnership for new drug delivery system development leveraging the disruptive Pressurized Gas eXpanded Liquid technology (PGX) to streamline drug formulations utilised in areas with unmet medical needs.
Pharmaceutical Technology
MAY 31, 2023
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval.
Pharmaceutical Technology
FEBRUARY 27, 2023
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval.
Let's personalize your content